Novavax

Novavax expects to produce 150 million doses of vaccines per month as early as May: CEO

Novavax expects to produce 150 million doses of vaccines per month as early as May: CEO

Novavax, Inc. (NASDAQ: NVAX), GlaxoSmithKline PLC (NYSE: GSK) – Analyzing Novavax Coronavirus Vaccine Data: 2 Taken by Analyst

Novavax sees vaccine approval in the UK first; in conversations with the FDA

Johnson & Johnson, Novavax vaccine data a ‘warning’ about the coronavirus variant

Vaccine hope driven by data from Novavax and J&J, but fears about new variants remain

Novavax’s stock rises as its Covid-19 vaccine outpaces J&J

Novavax praised by analysts as candidate for Covid-19 vaccine shows strong effectiveness

Novavax offers data from the first promising vaccine trial with tests against COVID variants

Care, Pfizer and Moderna: here comes Novavax

Live news from Coronavirus: Novavax effective against the UK variant; Emirates suspends flights to and from Britain | World News

Novavax coronavirus vaccine is 89.3% effective